Chargement en cours...
Viral hepatitis screening guideline before biological drug use in rheumatic patients
Biological drugs (tumor necrosis factor inhibitors, rituximab, tocilizumab, abatacept, and tofacitinib) are important treatment alternatives in rheumatology, particularly for resistant patients. However, they may cause hepatitis B virus (HBV) and hepatitis C virus (HCV) reactivation; for instance, H...
Enregistré dans:
| Publié dans: | Eur J Rheumatol |
|---|---|
| Auteurs principaux: | , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Medical Research and Education Association
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5042270/ https://ncbi.nlm.nih.gov/pubmed/27708965 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5152/eurjrheum.2015.150072 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|